Patents for A61P 19 - Drugs for skeletal disorders (81,981)
07/2011
07/14/2011US20110172219 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
07/14/2011US20110172191 Thieno-pyridine derivatives as mek inhibitors
07/14/2011US20110172189 Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use
07/14/2011US20110172182 Carboxyethylated Cyclodextrin Polysulfates Useful As Medicaments
07/14/2011US20110172159 Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment
07/14/2011US20110172157 Somatostatin analogues
07/14/2011US20110172154 Preventive and/or therapeutic and/or aggravation suppressing agent for human arthritis deformans
07/14/2011US20110172153 Screening methods using g-protein coupled receptors and related compositions
07/14/2011US20110172114 Compositions and methods for the treatment of immune related diseases
07/14/2011US20110171607 Biopulp
07/14/2011US20110171292 Peptide compositions and methods of use
07/14/2011US20110171275 Gastroretentive drug delivery system, preparation method and use thereof
07/14/2011US20110171270 Novel solid state forms of laquinimod and its sodium salt
07/14/2011US20110171268 Uricase compositions and methods of use
07/14/2011US20110171265 Composition Comprising Parasite Eggs and Methods for Isolation and Storage of Parasite Eggs
07/14/2011US20110171220 Pd-1 specific antibodies and uses thereof
07/14/2011US20110171207 Compositions and methods for treating inflammation and auto-immune diseases
07/14/2011US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor
07/14/2011US20110171187 Dietary supplements for promotion of growth, repair, and maintenance of bone and joints
07/14/2011US20110171172 Compounds for inhibiting ksp kinesin activity
07/14/2011US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds
07/14/2011US20110171144 Functional Micelles for Hard Tissue Targeted Delivery of Chemicals
07/14/2011US20110171130 A3 adenosine receptor antagonists and partial agonists
07/14/2011CA2786686A1 Enhanced bone healing
07/14/2011CA2786019A1 Plasma kallikrein binding proteins
07/14/2011CA2781576A1 Combination preparation including a corticosteroid and exosomes
07/14/2011CA2781223A1 Combination preparation including a cytokine antagonist and corticosteroid
07/13/2011EP2343314A2 Calcium fluoride phosphopeptide complexes
07/13/2011EP2343279A1 Fused-ring derivative and medical application of same
07/13/2011EP2343080A1 PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN
07/13/2011EP2343078A1 Light-stabilized pharmaceutical composition
07/13/2011EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
07/13/2011EP2343065A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
07/13/2011EP2342203A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
07/13/2011EP2342189A2 Selective estrogen receptor modulator for the treatment of osteoarthritis
07/13/2011EP2341934A2 Methods to reduce b-helper t cells to treat autoimmune diseases
07/13/2011EP2341915A1 Phosphorylated dendrimers as antiinflammatory drugs
07/13/2011EP2341900A1 A medicinal product and treatment
07/13/2011EP2341771A1 Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment
07/13/2011EP1934245B1 Y2 selective receptor agonists for therapeutic interventions
07/13/2011EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
07/13/2011EP1265878B1 A process for the preparation of epothilone analogs and intermediates
07/13/2011CN201894448U Cervical vertebra recovering pillow
07/13/2011CN102123995A Phenyl-alkyl piperazines having a modulating activity of tnf
07/13/2011CN102123763A Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
07/13/2011CN102123735A Agent for induction/maintenance of remission
07/13/2011CN102123709A A3 adenosine receptor allosteric modulators
07/13/2011CN102120013A Tea for clearing damp and removing arthritis
07/13/2011CN102119990A Chinese medicinal preparation for nourishing liver and kidney, supplementing qi, engendering blood, promoting blood circulation, removing obstruction in channels and relieving pain
07/13/2011CN102119989A Traditional Chinese medicine capsule for treating lumbar intervertebral disc protrusion, hyperosteogeny, periarthritis humeroscapularis, arthritis and cervical spondylosis
07/13/2011CN102119985A Quality control method of gout treating tablet
07/13/2011CN102119974A Externally-applied medicinal liquor
07/13/2011CN102119973A Quality control method for gardenia percolate
07/13/2011CN102119954A Application of glycine tomentella hayata. root and extract thereof in preparing medicament for treating rheumatoid arthritis
07/13/2011CN102119950A Compound elder composition for treating bone injury and preparation method and pharmaceutical application thereof
07/13/2011CN102119949A Medicament for treating acute pyogenic osteomyelitis
07/13/2011CN102119938A Folk Chinese herb medicine fruiting eight trigram-shaped maple root wine
07/13/2011CN102119918A Medicinal sustained-release preparation for treating osteomyelitis and preparation method and application thereof
07/13/2011CN102119821A Health-protecting material, application thereof in preparing health-protecting pillow and cushion, and health-protecting pillow and cushion
07/13/2011CN101589898B Multifunctional health care Chinese medicament pillow
07/13/2011CN101147774B Traditional Chinese medicinal composition for treating fracture and soft tissue bruise
07/13/2011CA2727890A1 Compounds, compositions and treatments for v-atpase related diseases
07/12/2011US7977481 Pyrimidinyl-thiophene kinase modulators
07/12/2011US7977469 biosynthesis of long chain polyunsaturated fatty acids like DHA (docosahexaenoic acid, 22:6, n-3); stress, diabetes, cancer, inflammatory disorders, and cardiovascular disorders
07/12/2011US7977464 Antibody molecules specific to human tumour necrosis factor alpha
07/12/2011US7977455 Analogues of GLP-1
07/12/2011US7977316 Prevention and treatment of amyloidogenic diseases
07/12/2011US7977312 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures
07/12/2011US7976874 Injectable calcium phosphate cements and the preparation and use thereof
07/12/2011CA2590159C Regimens for intra-articular viscosupplementation
07/12/2011CA2481767C Severe sepsis preventive therapeutic agent
07/12/2011CA2467676C Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis
07/12/2011CA2463505C Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3
07/12/2011CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide
07/12/2011CA2435611C Alpha-amino-n-hydroxy-acetamide derivatives
07/12/2011CA2393312C Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha.
07/12/2011CA2389685C Novel heterocyclic compounds and their use as medicaments
07/12/2011CA2352286C Intracellular targeted delivery of compounds by 70 kd heat shock protein
07/12/2011CA2341336C Elongase genes and uses thereof
07/12/2011CA2291514C Methods for evaluating tissue morphogenesis and activity
07/12/2011CA2162262C Methods for treating muscle diseases and disorders
07/07/2011WO2011081424A2 Functional foods effective for improving gout treatment, functional fermented foods such as kimchi, red pepper paste, soybean paste, soy sauce and the like, and production methods thereof
07/07/2011WO2011081173A1 Tetracyclic compound
07/07/2011WO2011059758A3 Apls for treating arthritis
07/07/2011WO2011021833A3 Composition for preventing or treating inflammation
07/07/2011US20110166234 Medicinal product and treatment
07/07/2011US20110166225 Oral liquid compositions of rhein or diacerein
07/07/2011US20110166223 Methods of inhibiting fgfr3 signaling
07/07/2011US20110166218 Methods for micronization of hydrophobic drugs
07/07/2011US20110166217 Pharmaceutical composition for prevention and/or treatment of bone loss
07/07/2011US20110166182 Selective Estrogen Receptor Modulator for the Treatment of Osteoarthritis
07/07/2011US20110166180 Method for treatment of bone diseases and fractures
07/07/2011US20110166176 Compounds and compositions as modulators of gpr119 activity
07/07/2011US20110166174 Compounds modulating c-kit and c-fms activity and uses therefor
07/07/2011US20110166173 3,5-disubstututed 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors
07/07/2011US20110166161 Heterocyclic carboxamide compounds
07/07/2011US20110166159 Compounds that modulate intracellular calcium
07/07/2011US20110166142 2-substituted isoflavonoid compounds, medicaments and uses
07/07/2011US20110166125 Substituted amides, manufacturing and use thereof as medicaments
07/07/2011US20110166110 Fused Ring Azadecalin Glucocorticoid Receptor Modulators